Skip to main content
. 2020 Nov 13;25(8):717–722. doi: 10.5863/1551-6776-25.8.717

Table 3.

Descriptive Analysis of Survival and Adverse Event Rates

Outcome Result
Survival, n (%)
 Survival to decannulation 24 (85.7)
 Survival to 30 days after decannulation 20 (71.4)
 Survival to discharge 18 (64.3)
Adverse events, n (%)
 Thrombus 9 (32.1)
 Hemorrhage
 Intracranial hemorrhage 7 (25)
 Gastrointestinal bleed 2 (7.1)
 Surgical site bleed 2 (7.1)